UMC’s board members
UMC’s board consists of six members and their alternates, appointed by WHO and by the Swedish government.
The operations of UMC as a WHO Collaborating Centre are governed by an agreement between WHO Headquarters and the Swedish government. The centre has an international board – WHO and the Swedish government each appoint three members and alternate members.
Since May 2019, the board has been chaired by Dr Filippa Nyberg, Chief Medical Officer, Karolinska University Hospital, and Associate Professor, Karolinska Institutet.
The members of the board are listed below.
Appointed by the Swedish government
- Dr Filippa Nyberg
Senior Consultant, Karolinska University Hospital, and Associate Professor, Karolinska Institutet - Dr Karin Meyer
CEO, Center for Translational Research - Mr Carl-Fredrik Högstedt
Head of Credit Investments, Skandia Investment Management
Alternates
- Dr Björn Eriksson
Director General of the Swedish Medical Products Agency - Professor Gert Ragnarsson
Professor and Scientific Advisor - Gabriel Wikström
National Coordinator for 2030 Agenda
Appointed by WHO
- Dr Rogério Gaspar
Director, Regulation and Prequalification, World Health Organization - Dr Fred Moin Siyoi
CEO, Pharmacy and Poisons Board, Kenya - Dr. V. G. Somani
Drugs Controller General of India Central Drugs Standard Control Organisation (CDSO) Ministry of Health and Family Welfare Government of India
Alternates
- Dr Shanthi Pal
Team Lead, Pharmacovigilance, World Health Organization - Dr Jun Kitahara
Director, International Information Group, Risk Communication Promotion Division, Safety, Pharmaceuticals and Medical Devices Agency (PMDA), Japan - Dr Juan Roldán Saelzer
Head of Pharmacovigilance Subdepartment of the Department National Medicines Agency at the Institute of Public Health of Chile